Vanessa has over 25 years' experience in the patent field. She has a talent for building long-term trusted relationships with clients having IP portfolios at all stages of development, from start-up companies to global corporations with complex interrelated patent cases, universities and spin-outs, always providing commercially focussed and proactive advice.
Vanessa leads HGF's medical devices team and has substantial experience of drafting and prosecuting patents with medtech and healthcare subject matter, such as drug delivery devices, spinal and other orthopaedic instruments, dental, knee and hip implants, fracture fixators, ventilators, EEG systems, ophthalmic technology, cardiovascular stents and catheters. In addition to medical devices, her other areas of expertise include advanced manufacturing, food technology and energy technology including gas, water and electricity infrastructure.
With a keen interest in improving diversity and inclusion, Vanessa has been active in the UK profession-wide IP Inclusive initiative since its inception, leading its North of England network and was appointed to the IP Inclusive Advisory Board in 2021. Vanessa was elected to the Board of HGF in August 2020 and is HGF’s Board Sponsor for DEI (Diversity, Equity and Inclusion).
Postgraduate Certificate in Intellectual Property Law (University of London)
HGF Limited specialises in chemistry, electronics, engineering and life sciences-related instructions and combines strong oppositions expertise with a powerful drafting and filing practice and litigation roster. The key patent attorney practitioners are: senior partner and head of electronics Harry Hutchinson in Sheffield; London-based head of engineering Matthew Dixon; chemistry practice head Gary Wilson in Glasgow; Kate Taylor in York, who directs the life sciences group; pharmaceutical team head Andrew Wells in Manchester; head of oppositions and appeals Chris Moore in Birmingham; energy practice head Craig Watson in Aberdeen; and Vanessa Stainthorpe in Sheffield, who leads the medical device department.
Named and interviewed in #WIPRDiversity21 as one of @WorldIPReview's Influential Women in IP in 2021. Vanessa Stainthorpe has more than 25 years of experience as a patent attorney and has been a board member for HGF since August 2020. She specialises in patent filing, prosecution and strategic IP advice in the mechanical engineering field with a particular specialism in medical technology. She leads HGF’s medical devices team and this year, she spoke at HGF’s annual IP in Healthcare conference and at its Child Health Technology event. She is heavily involved in IP Inclusive, which aims to improve D&I in IP, ensuring that HGF was one of the early signatories to the organisation’s charter. She set up and led the IP Inclusive North of England network, providing support to professionals across the region. She organised and hosted an “Allies” event to support D&I in June 2020 and presented follow up Q&A videos.
May 11th 2022
March 16th 2022
November 16th 2021
June 24th 2021
May 26th 2021
April 26th 2021
March 2nd 2021
January 14th 2021
March 3rd 2020
January 27th 2020
January 28th 2019
Vanessa is HGF’s Board Sponsor for Diversity, Equity and Inclusion and is responsible for HGF’s involvement in IP Inclusive, which is a network of intellectual property professionals working to improve diversity, equity and inclusion in our community. Vanessa is on the Advisory Board of IP Inclusive Management, is the lead for IP Inclusive’s North of England network and was one of the first signatories to the IP Inclusive Senior Leaders’ Pledge. Vanessa is a trained Mental Health First Aider.
Simulations offer a powerful tool in modern-day engineering. Subjecting designs to initial testing in a simulated environment will, for many designs, reduce costs owing to reduced needs to produce and …Read article
Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …Read article
After a challenging couple of years, we are delighted to invite you to join us for HGF’s eighth annual IP in Healthcare Conference. We will review the latest intellectual property …Event details
HGF is holding a webinar and an in-person event covering the UPC in Germany and Austria this Spring. The provisional phase of the Unified Patent Court (UPC) is now underway …Event details
HGF hosted a webinar on Wednesday 23rd March on Getting your first filing right. One of the most often asked questions of patent attorneys is: “when should we file?” Both …Event details
HGF Patent Attorney Dr Robert Weinert-Aplin is attending and speaking at the Manufacturing & Supply Chain Conference on 10th March 2022 in Milton Keynes, UK. The Manufacturing & Supply Chain …Event details
HGF Partner and Patent Attorney Craig Thomson and Patent Director Dr Jennifer Bailey write an article for The Microbiome Times on ELIGO v SNIPR: a reflection on IP strategies in …Read article
With news that the Austrian parliament has ratified the Protocol on the provisional application of the Agreement on a Unified Patent Court on 2 December 2021, the Unified Patent Court …Read article
If you would like to discuss how HGF could help you, contact one of our IP specialists.